Cargando…
Diminution in sperm quantity and quality in mouse models of Duchenne Muscular Dystrophy induced by a myostatin-based muscle growth-promoting intervention
Duchenne Muscular Dystrophy is a devastating disease caused by the absence of a functional rod-shaped cytoplasmic protein called dystrophin. Several avenues are being developed aimed to restore dystrophin expression in boys affected by this X-linked disease. However, its complete cure is likely to n...
Autores principales: | Vaughan, Danielle, Kretz, Oliver, Alqallaf, Ali, Mitchell, Robert, von der Heide, Jennie L, Vaiyapuri, Sakthivel, Matsakas, Antonios, Pasternack, Arja, Collins-Hooper, Henry, Ritvos, Olli, Ballesteros, Randy, Huber, Tobias B., Amthor, Helge, Mukherjee, Abir, Patel, Ketan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385695/ https://www.ncbi.nlm.nih.gov/pubmed/32782759 http://dx.doi.org/10.4081/ejtm.2019.8904 |
Ejemplares similares
-
A muscle growth-promoting treatment based on the attenuation of activin/myostatin signalling results in long-term testicular abnormalities
por: Vaughan, Danielle, et al.
Publicado: (2021) -
Inhibition of Activin/Myostatin signalling induces skeletal muscle hypertrophy but impairs mouse testicular development
por: Vaughan, Danielle, et al.
Publicado: (2020) -
Compression of morbidity in a progeroid mouse model through the attenuation of myostatin/activin signalling
por: Alyodawi, Khalid, et al.
Publicado: (2019) -
Differentiation of Murine C2C12 Myoblasts Strongly Reduces the Effects of Myostatin on Intracellular Signaling
por: Lautaoja, Juulia H., et al.
Publicado: (2020) -
Treatment with soluble activin type IIB-receptor improves bone mass and strength in a mouse model of Duchenne muscular dystrophy
por: Puolakkainen, Tero, et al.
Publicado: (2017)